Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hepatitis B; Kidney Failure, Chronic Phase 4 ClinicalTrials
Hepatitis; Hepatitis B Phase 4 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 3 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 3 ClinicalTrials
Diphtheria; Hepatitis B; Poliomyelitis Phase 3 ClinicalTrials
Cross Infection; Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Otitis; Otitis Media; Pneumonia; Streptococcal Infections Phase 3 ClinicalTrials
Acquired Immunodeficiency Syndrome; Communicable Diseases; Hepatitis; Hepatitis A; Hepatitis B; HIV Infections; Infection Phase 4 ClinicalTrials
Hepatitis B; Hepatitis B, Chronic Phase 4 ClinicalTrials
Hepatitis B Phase 3 ClinicalTrials
Influenza, Human; Pneumonia Phase 1 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Hepatitis B; Kidney Diseases; Renal Insufficiency, Chronic Phase 3 ClinicalTrials
Malaria Phase 1 ClinicalTrials
Hepatitis B Phase 3 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 4 ClinicalTrials
Hepatitis; Hepatitis A; Hepatitis B Phase 3 ClinicalTrials
Malaria Phase 2 ClinicalTrials
Papillomavirus Infections Phase 4 ClinicalTrials
Hepatitis; Hepatitis B; Kidney Failure, Chronic Phase 3 ClinicalTrials
CONTENTS